| Literature DB >> 6129883 |
B A Gould, R S Hornung, H Kieso, S Mann, E B Raftery.
Abstract
1 We have assessed the efficacy of Viskaldix, a combination of pindolol 10 mg and clopamide 5 mg using continuous intra-arterial ambulatory blood pressure monitoring. 2 Fourteen of the sixteen patients entered were studied on no therapy and following a minimum of 6 weeks at a constant dosage of Viskaldix. 3 Viskaldix produced a marked and consistent reduction of the blood pressure over the 24 h. The diurnal variation in the heart rate was decreased. 4 The results were compared with those of a similar study with once-daily pindolol where there was control during the day but not in the early morning when the blood pressures rose rapidly.Entities:
Mesh:
Substances:
Year: 1982 PMID: 6129883 PMCID: PMC1427550 DOI: 10.1111/j.1365-2125.1982.tb02044.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335